These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 23359527)

  • 21. Triple combination therapy with high-dose ampicillin/sulbactam, high-dose tigecycline and colistin in the treatment of ventilator-associated pneumonia caused by pan-drug resistant Acinetobacter baumannii: a case series study.
    Assimakopoulos SF; Karamouzos V; Lefkaditi A; Sklavou C; Kolonitsiou F; Christofidou M; Fligou F; Gogos C; Marangos M
    Infez Med; 2019 Mar; 27(1):11-16. PubMed ID: 30882373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study.
    Korbila IP; Michalopoulos A; Rafailidis PI; Nikita D; Samonis G; Falagas ME
    Clin Microbiol Infect; 2010 Aug; 16(8):1230-6. PubMed ID: 19732088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of intravenous colistin in preterm infants with nosocomial sepsis caused by Acinetobacter baumannii.
    Alan S; Yildiz D; Erdeve O; Cakir U; Kahvecioglu D; Okulu E; Ates C; Atasay B; Arsan S
    Am J Perinatol; 2014 Dec; 31(12):1079-86. PubMed ID: 24584997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of aerosolized colistin methanesulfonate therapy for extensively-drug-resistant Acinetobacter baumannii complex pneumonia and airway colonization.
    Hsieh TC; Chen FL; Ou TY; Jean SS; Lee WS
    J Microbiol Immunol Infect; 2016 Aug; 49(4):523-30. PubMed ID: 25442877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acinetobacter baumannii ventilator-associated pneumonia: epidemiology, clinical characteristics, and prognosis factors.
    Chaari A; Mnif B; Bahloul M; Mahjoubi F; Chtara K; Turki O; Gharbi N; Chelly H; Hammami A; Bouaziz M
    Int J Infect Dis; 2013 Dec; 17(12):e1225-8. PubMed ID: 24094525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and toxicity of high-dose nebulized colistin for critically ill surgical patients with ventilator-associated pneumonia caused by multidrug-resistant Acinetobacter baumannii.
    Jang JY; Kwon HY; Choi EH; Lee WY; Shim H; Bae KS
    J Crit Care; 2017 Aug; 40():251-256. PubMed ID: 28458172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nebulized colistin treatment of multi-resistant Acinetobacter baumannii pulmonary infection in critical ill patients].
    Pérez-Pedrero MJ; Sánchez-Casado M; Rodríguez-Villar S
    Med Intensiva; 2011 May; 35(4):226-31. PubMed ID: 21396739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eradication of multidrug-resistant Acinetobacter baumannii from the respiratory tract with inhaled colistin methanesulfonate: a matched case-control study.
    Kuo SC; Lee YT; Yang SP; Chen CP; Chen TL; Hsieh SL; Siu LK; Fung CP
    Clin Microbiol Infect; 2012 Sep; 18(9):870-6. PubMed ID: 21999321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acinetobacter baumannii: an important pathogen with multidrug resistance in newborns].
    Celik IH; Demirel G; Tatar Aksoy H; Saygan S; Canpolat FE; Uras N; Oğuz SS; Erdeve O; Dilmen U
    Mikrobiyol Bul; 2011 Oct; 45(4):716-22. PubMed ID: 22090302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of ventilator associated pneumonia with a new antibiotic adjuvant entity (ceftriaxone+sulbactam+disodium edetate) - A novel approach to spare carbapenems.
    Sathe P; Maddani S; Kulkarni S; Munshi N
    J Crit Care; 2017 Oct; 41():145-149. PubMed ID: 28535440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colistin alone or combined with sulbactam or carbapenem against A. baumannii in ventilator-associated pneumonia.
    Yilmaz GR; Guven T; Guner R; Kocak Tufan Z; Izdes S; Tasyaran MA; Acikgoz ZC
    J Infect Dev Ctries; 2015 May; 9(5):476-85. PubMed ID: 25989167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colistin against colistin-only-susceptible Acinetobacter baumannii-related infections: Monotherapy or combination therapy?
    Simsek F; Gedik H; Yildirmak MT; Iris NE; Türkmen A; Ersoy A; Ersöz M; Gücüyener A
    Indian J Med Microbiol; 2012; 30(4):448-52. PubMed ID: 23183471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP.
    Garnacho-Montero J; Ortiz-Leyba C; Jiménez-Jiménez FJ; Barrero-Almodóvar AE; García-Garmendia JL; Bernabeu-WittelI M; Gallego-Lara SL; Madrazo-Osuna J
    Clin Infect Dis; 2003 May; 36(9):1111-8. PubMed ID: 12715304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of aerosolized colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistin-only susceptible gram-negative bacteria.
    Tumbarello M; De Pascale G; Trecarichi EM; De Martino S; Bello G; Maviglia R; Spanu T; Antonelli M
    Chest; 2013 Dec; 144(6):1768-1775. PubMed ID: 23989805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose ampicillin-sulbactam as an alternative treatment of late-onset VAP from multidrug-resistant Acinetobacter baumannii.
    Betrosian AP; Frantzeskaki F; Xanthaki A; Georgiadis G
    Scand J Infect Dis; 2007; 39(1):38-43. PubMed ID: 17366011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors and outcomes of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia in the neonate: A case-case-control study.
    Thatrimontrichai A; Techato C; Dissaneevate S; Janjindamai W; Maneenil G; Kritsaneepaiboon S; Tanaanantarak P
    J Infect Chemother; 2016 Jul; 22(7):444-9. PubMed ID: 27229539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study.
    Kallel H; Hergafi L; Bahloul M; Hakim A; Dammak H; Chelly H; Hamida CB; Chaari A; Rekik N; Bouaziz M
    Intensive Care Med; 2007 Jul; 33(7):1162-1167. PubMed ID: 17530220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous vs intravenous plus aerosolized colistin for treatment of ventilator-associated pneumonia - a matched case-control study in neonates.
    Hussain K; Salat MS; Ambreen G; Mughal A; Idrees S; Sohail M; Iqbal J
    Expert Opin Drug Saf; 2020 Dec; 19(12):1641-1649. PubMed ID: 32892635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colistin and tigecycline susceptibility among multidrug-resistant Acinetobacter baumannii isolated from ventilator-associated pneumonia.
    Dizbay M; Altuncekic A; Sezer BE; Ozdemir K; Arman D
    Int J Antimicrob Agents; 2008 Jul; 32(1):29-32. PubMed ID: 18539006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii.
    Motaouakkil S; Charra B; Hachimi A; Nejmi H; Benslama A; Elmdaghri N; Belabbes H; Benbachir M
    J Infect; 2006 Oct; 53(4):274-8. PubMed ID: 16442632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.